Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ten arguments for a societal perspective in the economic evaluation of medical innovations.

× No keyword cloud information.

72 in total

Review 1. Dementia case management effectiveness on health care costs and resource utilization: a systematic review of randomized controlled trials.

Authors: C Pimouguet; T Lavaud; J F Dartigues; C Helmer
Journal: J Nutr Health Aging Date: 2010-10 Impact factor: 4.075

2. Real economics needs to reflect real decisions: a response to Johnson.

Authors: Mark Sculpher; Karl Claxton
Journal: Pharmacoeconomics Date: 2012-02-01 Impact factor: 4.981

3. Predicting productivity based on EQ-5D: an explorative study.

Authors: Marieke Krol; Elly Stolk; Werner Brouwer
Journal: Eur J Health Econ Date: 2013-06-13

4. The use of pharmacoeconomic evidence to support formulary decision making in Saudi Arabia: Methodological recommendations.

Authors: Sinaa A Al Aqeel; Mohammed Al-Sultan
Journal: Saudi Pharm J Date: 2011-12-24 Impact factor: 4.330

Review 5. Cost effectiveness of medication adherence-enhancing interventions: a systematic review of trial-based economic evaluations.

Authors: Edwin J M Oberjé; Reina J A de Kinderen; Silvia M A A Evers; Cees M J van Woerkum; Marijn de Bruin
Journal: Pharmacoeconomics Date: 2013-12 Impact factor: 4.981

6. Variation in the methodological approach to productivity cost valuation: the case of prostate cancer.

Authors: Paul Hanly; Rebecca Maguire; Frances Drummond; Linda Sharp
Journal: Eur J Health Econ Date: 2019-08-23

Review 7. Productivity costs in economic evaluations: past, present, future.

Authors: Marieke Krol; Werner Brouwer; Frans Rutten
Journal: Pharmacoeconomics Date: 2013-07 Impact factor: 4.981

Review 8. Estimating productivity costs in health economic evaluations: a review of instruments and psychometric evidence.

Authors: Kenneth Tang
Journal: Pharmacoeconomics Date: 2015-01 Impact factor: 4.981

9. Counting the cost of meningococcal disease : scenarios of severe meningitis and septicemia.

Authors: Claire Wright; Rebecca Wordsworth; Linda Glennie
Journal: Paediatr Drugs Date: 2013-02 Impact factor: 3.022

10. The scope of costs in alcohol studies: Cost-of-illness studies differ from economic evaluations.

Authors: Paul F van Gils; Heleen H Hamberg-van Reenen; Matthijs van den Berg; Luqman Tariq; G Ardine de Wit
Journal: Cost Eff Resour Alloc Date: 2010-07-06